nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 29th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:20PM
|
Aug 29th, 2022 12:20PM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 28th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:20AM
|
Aug 28th, 2022 05:20AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 27th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:39AM
|
Aug 27th, 2022 04:39AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 25th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:19AM
|
Aug 25th, 2022 09:19AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 23rd, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:12AM
|
Aug 23rd, 2022 11:12AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 21st, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 12:56PM
|
Aug 21st, 2022 12:56PM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 20th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:33PM
|
Aug 20th, 2022 02:33PM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 19th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 12:55PM
|
Aug 19th, 2022 12:55PM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 18th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:39AM
|
Aug 18th, 2022 04:39AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:nktr
|
https://www.indeed.com/cmp/nektar-therapeutics
|
Aug 17th, 2022 12:00AM
|
Open
|
Nektar Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
|
RRv1_100M_500M
|
San Francisco, CA
|
Howard W. Robin
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43.00
|
43.00
|
3.40
|
4.00
|
3.00
|
3.20
|
3.80
|
11.00
|
About a month
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:18AM
|
Aug 17th, 2022 10:18AM
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|